Literature DB >> 28025703

The biology of the ABCA3 lipid transporter in lung health and disease.

Michael F Beers1, Surafel Mulugeta2.   

Abstract

The lipid transporter, ATP-binding cassette class A3 (ABCA3), is a highly conserved multi-membrane-spanning protein that plays a critical role in the regulation of pulmonary surfactant homeostasis. Mutations in ABCA3 have been increasingly recognized as one of the causes of inherited pulmonary diseases. These monogenic disorders produce familial lung abnormalities with pathological presentations ranging from neonatal surfactant-deficiency-induced respiratory failure to childhood or adult diffuse parenchymal lung diseases for which specific treatment modalities remain limited. More than 200 ABCA3 mutations have been reported to date with approximately three quarters of patients presenting as compound heterozygotes. Recent advances in our understanding of the molecular basis underlying normal ABCA3 biosynthesis and processing and of the mechanisms of alveolar epithelial cell dysregulation caused by the expression of its mutant forms are beginning to emerge. These insights and the role of environmental factors and modifier genes are discussed in the context of the considerable variability in disease presentation observed in patients with identical ABCA3 gene mutations. Moreover, the opportunities afforded by an enhanced understanding of ABCA3 biology for targeted therapeutic strategies are addressed.

Entities:  

Keywords:  ABCA3; Compound heterozygous mutations; Inhertited pulmonary disease; Pulmonary surfactant; Surfactant deficiency

Mesh:

Substances:

Year:  2016        PMID: 28025703      PMCID: PMC5321817          DOI: 10.1007/s00441-016-2554-z

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  117 in total

Review 1.  ABCA3, a key player in neonatal respiratory transition and genetic disorders of the surfactant system.

Authors:  Donatella Peca; Renato Cutrera; Andrea Masotti; Renata Boldrini; Olivier Danhaive
Journal:  Biochem Soc Trans       Date:  2015-10       Impact factor: 5.407

2.  ABCA3-mediated choline-phospholipids uptake into intracellular vesicles in A549 cells.

Authors:  Yoshihiro Matsumura; Hiromichi Sakai; Mayumi Sasaki; Nobuhiro Ban; Nobuya Inagaki
Journal:  FEBS Lett       Date:  2007-06-06       Impact factor: 4.124

3.  ABCA3 deficiency presenting as persistent pulmonary hypertension of the newborn.

Authors:  Anette M Kunig; Thomas A Parker; Lawrence M Nogee; Steven H Abman; John P Kinsella
Journal:  J Pediatr       Date:  2007-09       Impact factor: 4.406

4.  ABCA3 mutations led to pulmonary fibrosis and emphysema with pulmonary hypertension in an 8-year-old girl.

Authors:  Chiharu Ota; Masato Kimura; Shigeo Kure
Journal:  Pediatr Pulmonol       Date:  2016-01-18

5.  Degradation of surfactant protein D by alveolar macrophages.

Authors:  Q Dong; J R Wright
Journal:  Am J Physiol       Date:  1998-01

Review 6.  Interfacial properties of pulmonary surfactant layers.

Authors:  R Wüstneck; J Perez-Gil; N Wüstneck; A Cruz; V B Fainerman; U Pison
Journal:  Adv Colloid Interface Sci       Date:  2005-08-24       Impact factor: 12.984

7.  Targeted inactivation of the murine Abca3 gene leads to respiratory failure in newborns with defective lamellar bodies.

Authors:  Markus Hammel; Geert Michel; Christina Hoefer; Matthias Klaften; Josef Müller-Höcker; Martin Hrabé de Angelis; Andreas Holzinger
Journal:  Biochem Biophys Res Commun       Date:  2007-06-11       Impact factor: 3.575

8.  Cell-based assay for high-throughput quantitative screening of CFTR chloride transport agonists.

Authors:  L V Galietta; S Jayaraman; A S Verkman
Journal:  Am J Physiol Cell Physiol       Date:  2001-11       Impact factor: 4.249

9.  Aberrant catalytic cycle and impaired lipid transport into intracellular vesicles in ABCA3 mutants associated with nonfatal pediatric interstitial lung disease.

Authors:  Yoshihiro Matsumura; Nobuhiro Ban; Nobuya Inagaki
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-08-01       Impact factor: 5.464

10.  Interference of bronchographic agents with lung surfactant.

Authors:  S F Schürch; M R Roach
Journal:  Respir Physiol       Date:  1976-10
View more
  27 in total

Review 1.  Surfactant protein disorders in childhood interstitial lung disease.

Authors:  Jagdev Singh; Adam Jaffe; André Schultz; Hiran Selvadurai
Journal:  Eur J Pediatr       Date:  2021-04-11       Impact factor: 3.183

2.  Downregulated expression of hsa_circ_0037515 and hsa_circ_0037516 as novel biomarkers for non-small cell lung cancer.

Authors:  Dunmei Zhao; Honggang Liu; Huachao Liu; Xueqing Zhang; Meng Zhang; Vijay Kumar Kolluri; Xulong Feng; Zhenglei He; Minghua Wang; Ting'an Zhu; Xiaolong Yan; Yinghui Zhou
Journal:  Am J Transl Res       Date:  2020-01-15       Impact factor: 4.060

3.  Aberrant lung remodeling in a mouse model of surfactant dysregulation induced by modulation of the Abca3 gene.

Authors:  Michael F Beers; Lars Knudsen; Yaniv Tomer; Julian Maronn; Ming Zhao; Matthias Ochs; Surafel Mulugeta
Journal:  Ann Anat       Date:  2016-12-26       Impact factor: 2.698

4.  Functional characterization of four ATP-binding cassette transporter A3 gene (ABCA3) variants.

Authors:  June Y Hu; Ping Yang; Daniel J Wegner; Hillary B Heins; Cliff J Luke; Fuhai Li; Frances V White; Gary A Silverman; F Sessions Cole; Jennifer A Wambach
Journal:  Hum Mutat       Date:  2020-04-01       Impact factor: 4.878

5.  Functional Genomics of ABCA3 Variants.

Authors:  Jennifer A Wambach; Ping Yang; Daniel J Wegner; Hillary B Heins; Cliff Luke; Fuhai Li; Frances V White; F Sessions Cole
Journal:  Am J Respir Cell Mol Biol       Date:  2020-10       Impact factor: 6.914

6.  A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19.

Authors:  Yadi Zhou; Yuan Hou; Jiayu Shen; Reena Mehra; Asha Kallianpur; Daniel A Culver; Michaela U Gack; Samar Farha; Joe Zein; Suzy Comhair; Claudio Fiocchi; Thaddeus Stappenbeck; Timothy Chan; Charis Eng; Jae U Jung; Lara Jehi; Serpil Erzurum; Feixiong Cheng
Journal:  PLoS Biol       Date:  2020-11-06       Impact factor: 8.029

Review 7.  Anti-inflammatory and anti-viral actions of anionic pulmonary surfactant phospholipids.

Authors:  Mari Numata; Dennis R Voelker
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2022-02-28       Impact factor: 5.228

Review 8.  The Role of ABC Transporters in Lipid Metabolism and the Comorbid Course of Chronic Obstructive Pulmonary Disease and Atherosclerosis.

Authors:  Stanislav Kotlyarov; Anna Kotlyarova
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 5.923

9.  The common ABCA3E292V variant disrupts AT2 cell quality control and increases susceptibility to lung injury and aberrant remodeling.

Authors:  Yaniv Tomer; Jennifer Wambach; Lars Knudsen; Ming Zhao; Luis R Rodriguez; Aditi Murthy; Frances V White; Alessandro Venosa; Jeremy Katzen; Matthias Ochs; Aaron Hamvas; Michael F Beers; Surafel Mulugeta
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-06-16       Impact factor: 6.011

10.  Unusual long survival despite severe lung disease of a child with biallelic loss of function mutations in ABCA-3.

Authors:  P El Boustany; R Epaud; C Grosse; F Barriere; E Grimont-Rolland; A Carsin; J C Dubus
Journal:  Respir Med Case Rep       Date:  2018-03-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.